| __timestamp | Axsome Therapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 1488000000 |
| Thursday, January 1, 2015 | 6776987 | 1525000000 |
| Friday, January 1, 2016 | 21199860 | 2111000000 |
| Sunday, January 1, 2017 | 19957616 | 1848000000 |
| Monday, January 1, 2018 | 23495055 | 1213000000 |
| Tuesday, January 1, 2019 | 53647067 | 1010000000 |
| Wednesday, January 1, 2020 | 70244579 | 997000000 |
| Friday, January 1, 2021 | 58060725 | 967000000 |
| Saturday, January 1, 2022 | 57947447 | 838000000 |
| Sunday, January 1, 2023 | 97944000 | 953000000 |
| Monday, January 1, 2024 | 187077000 | 998000000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, innovation is key. Teva Pharmaceutical Industries Limited and Axsome Therapeutics, Inc. have taken distinct paths in their research and development (R&D) spending over the past decade. From 2014 to 2023, Teva's R&D expenses have consistently dwarfed those of Axsome, with Teva investing nearly 20 times more in 2014. However, Axsome has shown a remarkable growth trajectory, increasing its R&D spending by over 2,000% from 2014 to 2023.
While Teva's R&D expenses peaked in 2016, reaching a staggering $2.1 billion, they have since decreased by about 55% by 2023. In contrast, Axsome's investment in innovation has surged, culminating in a record $97.9 million in 2023. This shift highlights Axsome's aggressive push towards innovation, potentially reshaping the competitive landscape in the pharmaceutical industry.
Comparing Innovation Spending: Novartis AG and Teva Pharmaceutical Industries Limited
Research and Development Investment: Pfizer Inc. vs Axsome Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. or Teva Pharmaceutical Industries Limited: Who Invests More in Innovation?
Research and Development Investment: Teva Pharmaceutical Industries Limited vs Summit Therapeutics Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Vericel Corporation
R&D Insights: How Teva Pharmaceutical Industries Limited and HUTCHMED (China) Limited Allocate Funds
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
Research and Development Investment: Biogen Inc. vs Axsome Therapeutics, Inc.
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Axsome Therapeutics, Inc.
Analyzing R&D Budgets: Axsome Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Axsome Therapeutics, Inc. vs MorphoSys AG